CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Perrigo Company PLC is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Perrigo Company PLC
The Sharp Building
Hogan Place, Dublin 2
Phone: +353 17094000p:+353 17094000 DUBLIN, D02 TY74  Ireland Ticker: PRGOPRGO
Business Summary
Perrigo Company plc is a provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. Its segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises of its consumer self-care business in the United States and Canada. It primarily provides its customers self-care products that are sold and marketed under the customer's own brands and/or exclusive brands. The CSCI segment comprises of its consumer self-care business outside of the United States and Canada, primarily in Europe and Australia. These products are developed, manufactured, marketed, and distributed by the Company. Its product categories include Upper Respiratory, Pain and Sleep-Aids, Skincare and Personal Hygiene, Digestive Health, and Nutrition. Its primary branded products are sold under brand names Compeed, Dr. Fresh, Firefly, Good Sense, Mederma, Nasonex, Solpadeine, Coldrex, and Physiomer, among others.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-YesYesYes-

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/28/202412/31/2023YesYes--Yes

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
2099 Food preparations, not elsewhere classified
2844 Perfumes, cosmetics, and other toilet preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board Orlando D.Ashford 55 5/6/2022 12/15/2020
President, Chief Executive Officer, Director PatrickLockwood-Taylor 55 6/8/2023 6/8/2023
Chief Financial Officer, Executive Vice President Eduardo G.Bezerra 48 5/16/2022 5/16/2022
12 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Elan Finance plc Ireland
Perrigo Investments, LLC United States
PERRIGO CORPORATION DESIGNATED ACTIVITY COMPANY THE SHARP BUILDING HOGAN PLACE IE
94 additional Subsidiary records available in full report.

Business Names
Business Name
Abtei Omega Pharma GmbH
Aco Hud Nordic AB
Adriatic BST D.o.o. Podruznica Zagreb
177 additional Business Names available in full report.

General Information
Number of Employees: 9,140 (As of 12/31/2023)
Outstanding Shares: 136,427,804 (As of 11/4/2024)
Shareholders: 4,117
Stock Exchange: NYSE
Federal Tax Id: 382799573
Email Address: investor@perrigo.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, December 2, 2024